XZenith Biopharm

XZenith Biopharm is an innovative pharmaceutical company rooted in China with a global vision, focusing on areas such as oncology, metabolic diseases, and infectious diseases. Established in 2002 with a registered capital of 100 million yuan, XZenith Biopharm primarily engages in the research and development of new molecular entity drugs. Since its inception, the company has invested over 2 billion yuan in the field of innovative drugs. It has now built a complete new drug R&D system, featuring professional platforms from new drug structure design, evaluation, and candidate compound selection to clinical research and new drug marketing applications.The company has successively passed the Intellectual Property Management System and ISO9001 Quality Management System certifications. It holds a leading position in China’s drug research and development sector and is committed to building a world-class innovative drug research platform.